Sort
51,593 grants matching “hepatitis”
Diurnal regulation of MTP and plasma lipids
$415,812M Mahmood Hussain · Suny Downstate Medical Center · R01 · FY2010 · DK
Structural Basis of APOBEC Functions and HIV Restriction
$415,810Xiaojiang S Chen · University Of Southern California · R01 · FY2021 · AI
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axis
$415,800Zhong-Bin Deng · University Of Louisville · R01 · FY2018 · DK
Cortical representations and plasticity: Neurons and astrocytes
$415,800Mriganka Sur · Massachusetts Institute Of Technology · R01 · FY2010 · EY
Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV
$415,798Bachir Taouli · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DK
Regulation of chronic obstructive pulmonary disease by parsnip polyphenols
$415,780Kee-Hong Kim · Purdue University · R21 · FY2025 · AT
Molecular Basis of Human Hepatic Progenitor Cell Formation
$415,749Stephen A Duncan · Medical University Of South Carolina · R01 · FY2018 · DK
Effective PET Imaging in Liver Cancer
$415,716Zhenghong Lee · Case Western Reserve University · R01 · FY2009 · CA
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and women
$415,708Simin Liu · Brown University · R01 · FY2022 · DK
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome
$415,684Richard Joseph Johnson · University Of Colorado Denver · R01 · FY2019 · DK
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome
$415,684Richard Joseph Johnson · University Of Colorado Denver · R01 · FY2017 · DK
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic Syndrome
$415,684Richard Joseph Johnson · University Of Colorado Denver · R01 · FY2018 · DK
HDL metabolism: Influence of extracellular lipases
$415,681Daniel James Rader · University Of Pennsylvania · R37 · FY2018 · HL
INTRON A MONOTHERAPY VS INTRON A+ RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C
$415,629Massachusetts General Hospital · M01 · FY2000 · RR
INTRON A VS INTRON A PLUS RIBAVIRIN AT 2 DOSES TO TREAT CHRONIC HEPATITIS C
$415,629Massachusetts General Hospital · M01 · FY2000 · RR
Development of Preventative and Therapeutic HCV Vaccines
$415,608David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2006 · AI
CARD14 is essential for hepatitis C virus replication and activation of NFKB
$415,578Timothy L Tellinghuisen · Scripps Florida · R01 · FY2013 · DK
METABOLISM OF GENETIC VARIANTS OF APOLIPOPROTEIN B
$415,562Washington University · R37 · FY2002 · HL
Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic HBV
$415,560Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2022 · CA
CORE--LABORATORY ANIMAL FACILITY
$415,548Robert C Young · Fox Chase Cancer Center · P30 · FY2009 · CA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM
$415,530New York Academy Of Medicine · R01 · FY2002 · DA
Multicenter AIDS Cohort Study
$415,530Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · AI
HAART optimism, drug use and risky sexual behavior among MSM in British Columbia.
$415,527Robert S Hogg · Simon Fraser University · R01 · FY2011 · DA
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$415,502Michael Ohliger · University Of California, San Francisco · R01 · FY2021 · DK
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH
$415,502Michael Ohliger · University Of California, San Francisco · R01 · FY2022 · DK